首页|新型炎症指标对急性肺栓塞诊断及预后价值研究进展

新型炎症指标对急性肺栓塞诊断及预后价值研究进展

扫码查看
急性肺栓塞(APE)是常见的急危重心血管疾病之一。目前,用于诊断APE的方法主要依赖影像学检查和实验室检查。常用的影像学检测方法复杂,且还有耗时长、急重症患者搬运不便、检查费用高昂等缺点,因此,探寻一种简单、经济、有效的评估方法,对急性非高危肺栓塞患者诊断及预后具有重要临床意义。免疫/炎症反应是血管疾病发病机制中的一个重要环节,血液中具有代表性的指标包括中性粒细胞/淋巴细胞比值、单核细胞相关指标、血小板/淋巴细胞比值、全身免疫炎症指数等新型炎症指标。该文重点阐述了新型炎症指标对APE患者的诊断及预后的预测价值。
Research progress of novel inflammatory indicators in the diagnosis and prognosis of acute pulmonary embolism
Acute pulmonary embolism(APE)is one of the common acute and critical cardiovascular diseases.Currently,the methods used to diagnose APE rely on imaging and laboratory tests.The commonly used imaging detection methods are complex,consuming time,inconvenient handling for acute and severe pa-tients and high examination cost.Therefore,exploring a simple,economical and effective evaluation method for acute non-high-risk pulmonary embolism patients has important clinical significance.Immune/inflammatory response plays an important role in the pathogenesis of vascular disease.Representative indicators in blood in-clude neutrophil/lymphocyte ratio,monocyte-related indicators,platelet/lymphocyte ratio,systemic immune/inflammatory index,etc.This paper focused on the value of novel inflammatory markers in predicting the diag-nosis and prognosis of APE patients.

Novel inflammatory indicatorsAcute diseasePulmonary embolismDiagnosisPrognosisReview

李丽华、武云

展开 >

新疆医科大学第一附属医院全科医学科,新疆乌鲁木齐 841100

新型炎症指标 急性病 肺栓塞 诊断 预后 综述

国家自然科学基金项目

81860096

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(4)
  • 34